Atlas Trials

Use of a Combined Regimen of Fluoxetine, Prednisolone and Ivermectin in the Treatment of Mild COVID-19 to Prevent Disease Progression Progression in Papua New Guinea

Clinical trial NCT05283954 · WITHDRAWN

Trial details

NCT number
NCT05283954
Sponsor
Oriol Mitja
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
SARS-CoV2 InfectionCOVID-19
Start date
2022-05-01
Primary completion
2022-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.